Who owns the AVICEDA THERAPEUTICS trademark?

The AVICEDA THERAPEUTICS trademark is owned by Aviceda Therapeutics Inc..

What class is the AVICEDA THERAPEUTICS trademark registered in?

The AVICEDA THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for AVICEDA THERAPEUTICS?

The USPTO serial number for AVICEDA THERAPEUTICS is 88474033.

What is the registration number for AVICEDA THERAPEUTICS?

AVICEDA THERAPEUTICS is registered under USPTO registration number 6081669.

AVI

USPTO Trademark Record

REGISTERED

AVICEDA THERAPEUTICS

SN 88474033·Reg 6081669·Filed Jun 14, 2019

Owner Aviceda Therapeutics Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

AVICEDA THERAPEUTICS (Serial No. 88474033), Registration No. 6081669, is a registered US trademark filed on Jun 14, 2019 by Aviceda Therapeutics Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

renewal grace 6y period: December 16, 202648 days remaining

Mark Intelligence

AVICEDA THERAPEUTICS (Reg. #6081669) is a registered US trademark that has been protecting its owner, Aviceda Therapeutics Inc., since 2019. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 14, 2019

SERIAL

88474033

REG#

6081669

REGISTERED

Jun 16, 2020

Owner

Applicant

Aviceda Therapeutics Inc.

Entity

Corporation

State

Address

One Broadway, 14th Floor, Cambridge, MA, 02142

Country

Attorney

NameSusan Neuberger Weller

Law firm

Susan Neuberger Weller MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C

Address

555 12th Street NW, Suite 1100, WASHINGTON, DC 20004, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 14, 2019

Serial Number88474033

Registration No.6081669

Registration DateJun 16, 2020

Status DateJun 16, 2020

Published for OppositionOct 15, 2019

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jun 14, 2019

First use in commerce: Jun 14, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

27 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jun 16, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jul 20, 2021

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jul 20, 2021

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 20, 2021

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jun 16, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 12, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 09, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 30, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Apr 30, 2020

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Apr 14, 2020

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Apr 14, 2020

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 10, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 15, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Oct 15, 2019

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 25, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT E-MAILED

Sep 09, 2019

EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 09, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Sep 09, 2019

EXAMINERS AMENDMENT -WRITTEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 09, 2019

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

ASSIGNED TO LIE

Sep 09, 2019

ASSIGNED TO LIE

EXAMINER'S AMENDMENT ENTERED

Sep 09, 2019

EXAMINER'S AMENDMENT ENTERED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 07, 2019

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Sep 07, 2019

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Sep 07, 2019

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 06, 2019

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 27, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 18, 2019

NEW APPLICATION ENTERED

AVICEDA THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Aviceda Therapeutics Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Susan Neuberger Weller

Industries

USPTO Deadlines

Compare

Resources

Company